2026

Thank you, L&K SPINE! On behalf of the SPINEMarketGroup team, we sincerely appreciate your support as a PLATINUM Sponsor for 2026. We are proud to welcome L&K SPINE as a sponsor for the first time and look forward to starting this journey together. About L&K Spine L&K Biomed, whose name stands for Learning & Knowledge Biomed, applies knowledge … [Read more...] about We are proud to announce that L&K SPINE will be a Sponsor of SPINEMarketGroup in 2026!

On May 16, 2026, L&K Biomed received FDA 510(k) clearance for the BluEx-C, a height-expandable cervical interbody cage. The clearance lands at the right moment for a Korean spine company that has spent the better part of the past three years systematically building its U.S. regulatory footprint — and it does so in a segment that, by the company's own characterization, has … [Read more...] about L&K Biomed Clears the FDA with a Height-Expandable Cervical Cage — Entering a Segment Where Almost Nobody Plays

Westmont, Illinois – SpineCraft, a U.S.-based spine surgery systems developer and manufacturer, announces U.S. FDA 510(k) clearance of the ANTERIS Thoracolumbar Plate System, a comprehensive anterior fixation solution designed to provide supplemental stabilization for anterior lumbar interbody fusion procedures. The ANTERIS plate system is intended for use with anterior … [Read more...] about SpineCraft Announces U.S. FDA 510(k) Clearance of ANTERIS Thoracolumbar Plate System

The No Surprises Act was designed to protect Americans from unexpected medical bills. Five years later, the patient may be better protected — but the system created to settle the remaining disputes is producing a different problem. In some cases, arbitration awards appear far removed from the prices paid elsewhere in the market, turning a law built around patient protection … [Read more...] about How a $1,400 Spine Procedure Became a $34,000 Arbitration Award Under the No Surprises Act

Florence, SC, May 18, 2026 (GLOBE NEWSWIRE) -- DeGen Medical announced continued expansion of its patient-specific implant (PSI) platform designed to provide surgeons with patient-specific solutions for complex spinal pathologies while maintaining compatibility with a streamlined off-the-shelf workflow. DeGen Medical offers patient-specific implants, off-the-shelf implant … [Read more...] about DeGen Medical Expands Patient-Specific Spine Platform

On May 18, Boston Scientific announced a $1.5 billion investment for an approximate 34% equity stake in MiRus LLC, a privately held company based in Georgia and focused on biomaterials, implants, and procedural solutions for cardiovascular and orthopedic diseases. Most of the early coverage has naturally focused on the TAVR opportunity. That is where the clearest near-term … [Read more...] about Boston Scientific Puts $1.5 Billion on MiRus: Why the Spine Market Should Look Beyond TAVR

BELGRADE, Mont., May 13, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights First Quarter 2026 … [Read more...] about Xtant Medical Reports First Quarter 2026 Financial Results

Robotic guidance, navigation and planning are no longer experimental ideas in spine. They are already part of the market. Different systems follow different strategies, but the underlying message is the same: robotics has become part of how major spine companies want to compete. Still, most of what we call spine robotics today remains robotic assistance. The surgeon is still … [Read more...] about Autonomous Pedicle Screw Placement: Is Spine Robotics Ready for the Next Step?

In recent weeks, much of the spine market discussion has focused on Globus Medical and the negative market reaction that followed otherwise strong operating results. But Globus is not alone. Medtronic, one of its most direct competitors in spine technology, has also been under pressure. Its stock recently hit a reported 52-week low at $77.15, and by May 11, 2026, was quoted … [Read more...] about Medtronic Hits a 52-Week Low: What Is the Market Seeing?

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, … [Read more...] about SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon

There are reimbursement disputes that affect only the margins of a market. Others say something more structural about the direction of the industry. The recent statement from leading U.S. spine surgery societies on cervical fusion implant denials belongs to the second category. The issue is not a new device seeking early coverage, nor an experimental technology asking for … [Read more...] about Cervical Fusion Implant Denials: Why Spine Societies Are Pushing Back

CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora’s proprietary DEXA Technology® platform. The newly issued patent, U.S. Patent No. … [Read more...] about Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported … [Read more...] about Carlsmed® Reports First Quarter 2026 Financial